Stephanie D Jones

US Patent:

20130066342, Mar 14, 2013

Filed:

Sep 13, 2011

Appl. No.:

13/231586

Inventors:

Kent Dell - Redwood City CA, US
Theodore Ketai - San Francisco CA, US
Tanmay Mishra - Philadelphia PA, US
Stephanie Jones - Naperville IL, US
Jacob Greenberg - Mountain View CA, US
Michael Hong - San Francisco CA, US
Daniel Hale - Belmont CA, US
Francisco Valencia - East Palo Alto CA, US
Steven Tyler - Portola Valley CA, US

Assignee:

ABBOTT CARDIOVASCULAR SYSTEMS, INC. - Santa Clara CA

International Classification:

A61B 17/03

US Classification:

606151

Abstract:

The invention provides devices, systems and methods for tissue approximation and repair at treatment sites. The devices, systems and methods of the invention will find use in a variety of therapeutic procedures, including endovascular, minimally-invasive, and open surgical procedures, and can be used in various anatomical regions, including the abdomen, thorax, cardiovascular system, heart, intestinal tract, stomach, urinary tract, bladder, lung, and other organs, vessels, and tissues. The invention is particularly useful in those procedures requiring minimally-invasive or endovascular access to remote tissue locations, where the instruments utilized must negotiate long, narrow, and tortuous pathways to the treatment site. In addition, many of the devices and systems of the invention are adapted to be reversible and removable from the patient at any point without interference with or trauma to internal tissues.

US Patent:

20230129301, Apr 27, 2023

Filed:

Jul 18, 2022

Appl. No.:

17/813240

Inventors:

- Skokie IL, US
Sean Dennis Simpson - Evanston IL, US
Michael Koepke - Chicago IL, US
Stephanie Rhianon Jones - Evanston IL, US

International Classification:

C12P 19/34
C12P 7/04
C12N 1/20
C12N 1/32
G16B 5/10
G16B 20/50

Abstract:

The disclosure provides genetically engineered C1-fixing microorganisms capable of producing nanobodies. Additionally, the disclosure provides engineered microorganisms comprising one or more disrupted genes to strategically divert carbon flux away from nonessential or undesirable products towards products and/or co-products of interest. The disclosure enables co-production of useful chemicals from gaseous substrates.

US Patent:

20230050887, Feb 16, 2023

Filed:

Jul 18, 2022

Appl. No.:

17/813274

Inventors:

- Skokie IL, US
Sean Dennis Simpson - Evanston IL, US
Michael Koepke - Chicago IL, US
Stephanie Rhianon Jones - Evanston IL, US

International Classification:

C12N 15/117
C12N 15/74

Abstract:

The disclosure provides genetically engineered microorganisms capable of producing antigen-binding molecules. Additionally, the disclosure provides engineered microorganisms comprising one or more disrupted genes to strategically divert carbon flux away from undesirable products towards products, and optionally co-products, of interest. Further, the disclosure enables co-production of useful chemicals from gaseous substrates.

US Patent:

20210403883, Dec 30, 2021

Filed:

Aug 30, 2021

Appl. No.:

17/461102

Inventors:

- Alameda CA, US
Derek Lorin Greenfield - Kensington CA, US
Noah Charles Helman - El Cerrito CA, US
Stephanie Rhianon Jones - Berkeley CA, US
Baolong Zhu - Johnston IA, US

International Classification:

C12N 9/02
C12N 15/70
C12N 15/75
C12N 15/77

Abstract:

Improved soluble methane monooxygenases and soluble methane monooxygenase systems are provided.

US Patent:

20200360018, Nov 19, 2020

Filed:

Aug 7, 2020

Appl. No.:

16/987582

Inventors:

- SANTA CLARA CA, US
Theodore KETAI - San Francisco CA, US
Tanmay MISHRA - Mountain View CA, US
Stephanie JONES - Naperville IL, US
Jacob GREENBERG - Mountain View CA, US
Michael HONG - Emeryville CA, US
Daniel HALE - Belmont CA, US
Francisco VALENCIA - East Palo Alto CA, US
Steven TYLER - Portola Valley CA, US

Assignee:

ABBOTT CARDIOVASCULAR SYSTEMS INC. - SANTA CLARA CA

International Classification:

A61B 17/08
A61B 17/10
A61F 2/24

Abstract:

The invention provides devices, systems and methods for tissue approximation and repair at treatment sites. The devices, systems and methods of the invention will find use in a variety of therapeutic procedures, including endovascular, minimally-invasive, and open surgical procedures, and can be used in various anatomical regions, including the abdomen, thorax, cardiovascular system, heart, intestinal tract, stomach, urinary tract, bladder, lung, and other organs, vessels, and tissues. The invention is particularly useful in those procedures requiring minimally-invasive or endovascular access to remote tissue locations, where the instruments utilized must negotiate long, narrow, and tortuous pathways to the treatment site. In addition, many of the devices and systems of the invention are adapted to be reversible and removable from the patient at any point without interference with or trauma to internal tissues.

US Patent:

20200172881, Jun 4, 2020

Filed:

Jul 6, 2018

Appl. No.:

16/629018

Inventors:

- Alameda CA, US
Derek Lorin GREENFIELD - Kensington CA, US
Noah Charles HELMAN - El Cerrito CA, US
Stephanie Rhianon JONES - Evanston IL, US
Baolong ZHU - Zionsville IN, US

International Classification:

C12N 9/02
C12N 15/70
C12N 15/75
C12N 15/77

Abstract:

Improved soluble methane monooxygenases and soluble methane monooxygenase systems are provided.

US Patent:

20200078019, Mar 12, 2020

Filed:

Nov 18, 2019

Appl. No.:

16/687096

Inventors:

- SANTA CLARA CA, US
Theodore KETAI - San Francisco CA, US
Tanmay MISHRA - Philadelphia PA, US
Stephanie JONES - Naperville IL, US
Jacob GREENBERG - Mountain View CA, US
Michael HONG - San Francisco CA, US
Daniel HALE - Belmont CA, US
Francisco VALENCIA - East Palo Alto CA, US
Steven TYLER - Portola Valley CA, US

Assignee:

ABBOTT CARDIOVASCULAR SYSTEMS INC. - SANTA CLARA CA

International Classification:

A61B 17/08
A61F 2/24
A61B 17/10

Abstract:

The invention provides devices, systems and methods for tissue approximation and repair at treatment sites. The devices, systems and methods of the invention will find use in a variety of therapeutic procedures, including endovascular, minimally-invasive, and open surgical procedures, and can be used in various anatomical regions, including the abdomen, thorax, cardiovascular system, heart, intestinal tract, stomach, urinary tract, bladder, lung, and other organs, vessels, and tissues. The invention is particularly useful in those procedures requiring minimally-invasive or endovascular access to remote tissue locations, where the instruments utilized must negotiate long, narrow, and tortuous pathways to the treatment site. In addition, many of the devices and systems of the invention are adapted to be reversible and removable from the patient at any point without interference with or trauma to internal tissues.

US Patent:

20200048639, Feb 13, 2020

Filed:

Feb 17, 2018

Appl. No.:

16/486459

Inventors:

- Emeryville CA, US
Derek Lorin GREENFIELD - Kensington CA, US
Noah Charles HELMAN - El Cerrito CA, US
Stephanie Rhianon JONES - Berkeley CA, US
Baolong ZHU - San Diego CA, US

International Classification:

C12N 15/52
C12P 7/42
C12N 9/02

Abstract:

Provided are engineered organisms which can convert methane or methanol to 3-hydroxypropionate.